Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
Номер патента: EP2041160A2
Опубликовано: 01-04-2009
Автор(ы): Jeanne Menez-Jamet, Kostantinos Kosmatopoulos (Kostas), Stephanie Graff-Dubois
Принадлежит: Vaxon Biotech SA
Опубликовано: 01-04-2009
Автор(ы): Jeanne Menez-Jamet, Kostantinos Kosmatopoulos (Kostas), Stephanie Graff-Dubois
Принадлежит: Vaxon Biotech SA
Реферат: The present invention relates to the field of peptide immunotherapy. In particular, the invention pertains to a method for identifying a HLA-B*0702-restricted cryptic epitope in an antigen, and to a method for increasing its immunogenicity. The invention also provides novel methods and materials for efficiently treating patients having an HLA- B*0702 phenotype.
Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy
Номер патента: US8465747B2. Автор: Jeanne Menez-Jamet,Kostantinos (Kostas) Kosmatopoulos,Stephanie Graff-Dubois. Владелец: Vaxon Biotech SA. Дата публикации: 2013-06-18.